Pharma Giants Compete Intensely over Metsera Acquisition and the Weight-Loss Drug Race
In a move that has escalated competition in the growing obesity treatment market, Danish pharmaceutical company Novo Nordisk A/S (NASDAQ: NVO) has made an unsolicited
